Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Phase I Study

COMPASS Pathways (CMPS.Q) reported further results from a Phase I study on their COMP360 psilocybin conducted at King’s College London. The study was a randomized, double-blind, placebo-controlled study intended…